At the same time, as Fierce Pharma has noted, the rise of compounded alternatives and evolving IP dynamics has introduced parallel supply channels that are reshaping market share, pricing and forecasting for branded GLP-1 portfolios, including Ozempic and Wegovy
Elkind-Hirsch KE, Chappell N, Seidemann E, Storment J, Bellanger D
Injecting within a day or two of the same time each week keeps medication levels stable and reduces the variability in side effects that comes from irregular injection schedules
Holzinger M, Le Goff A, Cosnier S
[13] The 2019 ESC guidelines on diabetes, prediabetes, and CVD developed in collaboration with the EASD, which were updated briefly from the 2013 ESC guidelines, recommended liraglutide, semaglutide, or dulaglutide for T2DM and CVD patients or those with high/very high CV risk to reduce CV events (Class 1a) [14]
The medication that produces more weight loss actually had fewer people quitting due to stomach problems